Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Behav Brain Res ; 315: 1-9, 2016 12 15.
Artigo em Inglês | MEDLINE | ID: mdl-27515286

RESUMO

Levodopa (l-DOPA) has been proved to reverse the pathologic neuron activities in many brain regions related to Parkinson's disease (PD). But little is known about the effect of l-DOPA on the altered electrophysiological coherent activities between pedunculopontine nucleus (PPN) and motor cortex. To investigate this, local field potentials (LFPs) of PPN and primary motor cortex (M1) were recorded simultaneously in control, 6-hydroxydopamine lesioned and lesioned rats with l-DOPA chronic treatment. The results revealed that in resting state, chronic l-DOPA treatment could correct the suppressed power of LFPs in PPN and M1 in low-frequency band (1-7Hz) and the enhanced power in high-frequency band (7-70Hz in PPN and 12-70Hz in M1) of lesioned rats. In locomotor state, l-DOPA treatment could correct the alterations in most of frequency bands except the δ band in PPN and α band in M1. Moreover, l-DOPA could also reverse the altered coherent relationships caused by dopamine depletion in resting state between PPN and M1 in ß band. And in locomotor state, l-DOPA had therapeutic effect on the alterations in δ and ß bands but not in the α band. These findings provide evidence that l-DOPA can reverse the altered LFP activities in PPN and M1 and their relationships in a rat model of PD, which contributes to better understanding the electrophysiological mechanisms of the pathophysiology and therapy of PD.


Assuntos
Antiparkinsonianos/farmacologia , Potenciais Evocados/efeitos dos fármacos , Levodopa/farmacologia , Córtex Motor/efeitos dos fármacos , Doença de Parkinson/patologia , Núcleo Tegmental Pedunculopontino/efeitos dos fármacos , Animais , Antiparkinsonianos/uso terapêutico , Benserazida/farmacologia , Benserazida/uso terapêutico , Condicionamento Operante/efeitos dos fármacos , Modelos Animais de Doenças , Análise de Fourier , Levodopa/uso terapêutico , Locomoção/efeitos dos fármacos , Masculino , Oxidopamina/toxicidade , Doença de Parkinson/tratamento farmacológico , Doença de Parkinson/etiologia , Ratos , Ratos Wistar , Fatores de Tempo
2.
Neuroscience ; 330: 57-71, 2016 08 25.
Artigo em Inglês | MEDLINE | ID: mdl-27238892

RESUMO

Several studies have suggested that the thalamic centromedian-parafascicular (CM/PF or the PF in rodents) is implicated in the pathophysiology of Parkinson's disease (PD). However, inconsistent changes in the neuronal firing rate and pattern have been reported in parkinsonian animals. To investigate the impact of a dopaminergic cell lesion on PF extracellular discharge in behaving rats, the PF neural activities in the spike and local field potential (LFP) were recorded in unilaterally 6-hydroxydopamine- (6-OHDA) lesioned and neurologically intact control rats during rest and limb movement. During rest, the two PF neuronal subtypes was less spontaneously active, with no difference in the spike firing rates between the control and lesioned rats; only the lesioned rats reshaped their spike firing pattern. Furthermore, the simultaneously recorded LFP in the lesioned rats exhibited a significant increase in power at 12-35 and 35-70Hz and a decrease in power at 0.7-12Hz. During the execution of a voluntary movement, two subtypes of PF neurons were identified by a rapid increase in the discharge activity in both the control and lesioned rats. However, dopamine lesioning was associated with a decrease in neuronal spiking fire rate and reshaping in the firing pattern in the PF. The simultaneously recorded LFP activity exhibited a significant increase in power at 12-35Hz and a decrease in power at 0.7-12Hz compared with the control rats. These findings indicate that 6-OHDA induces modifications in PF spike and LFP activities in rats during rest and movement and suggest that PF dysfunction may be an important contributor to the pathophysiology of parkinsonian motor impairment.


Assuntos
Potenciais de Ação/fisiologia , Núcleos Intralaminares do Tálamo/fisiopatologia , Atividade Motora/fisiologia , Neurônios/fisiologia , Transtornos Parkinsonianos/fisiopatologia , Animais , Dopamina/metabolismo , Lateralidade Funcional , Imuno-Histoquímica , Núcleos Intralaminares do Tálamo/patologia , Masculino , Microeletrodos , Neurônios/patologia , Oxidopamina , Transtornos Parkinsonianos/patologia , Ratos Wistar , Fatores de Tempo
3.
Behav Brain Res ; 305: 57-64, 2016 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-26924016

RESUMO

The pedunculopontine nucleus (PPN) is a new deep brain stimulation target for treating Parkinson's disease (PD). But the alterations of the PPN electrophysiological activities in PD are still debated. To investigate these potential alterations, extracellular single unit and local field potential (LFP) activities in the PPN were recorded in unilateral hemispheric 6-hydroxydopamine (6-OHDA) lesioned rats and in control rats, respectively. The spike activity results revealed two types of neurons (Type I and Type II) with distinct electrophysiological characteristics in the PPN. Both types of neurons had increased firing rate and changed firing pattern in lesioned rats when compared to control rats. Specifically, Type II neurons showed an increased firing rate when the rat state was switched from rest to locomotion. The LFP results demonstrated that lesioned rats had lower LFP power at 0.7-12Hz and higher power at 12-30Hz than did control animals in either resting or locomotor state. These findings provide a better understanding of the effects of 6-OHDA lesion on neuronal activities in the PPN and also provide a proof of the link between this structure and locomotion, which contributes to better understanding the mechanisms of the PPN functioning in the pathophysiology of PD.


Assuntos
Potenciais de Ação/fisiologia , Neurônios/fisiologia , Doença de Parkinson/patologia , Núcleo Tegmental Pedunculopontino/patologia , Potenciais de Ação/efeitos dos fármacos , Adrenérgicos/toxicidade , Animais , Modelos Animais de Doenças , Estimulação Elétrica , Masculino , Feixe Prosencefálico Mediano/lesões , Neurônios/efeitos dos fármacos , Oxidopamina/toxicidade , Doença de Parkinson/etiologia , Doença de Parkinson/fisiopatologia , Desempenho Psicomotor/efeitos dos fármacos , Ratos , Ratos Wistar , Estatísticas não Paramétricas , Tirosina 3-Mono-Oxigenase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA